Group Means (SD) of Demographic and clinical data, Neuropsychological test scores, and Median Target Reaction Times.

<p><i>Note:</i> all tests corrected for heteroscedacity; HC, healthy controls; ROP, Recent Onset Psychosis patients; NROP, ROP no schizophrenia; SROP, ROP with schizophrenia; Ns, p>.05; IQ, Intelligence Quotient; PANSS Pos, PANSS Positive scale; PANSS Neg, PANSS Negative scale; PANSS Gen, PANSS General scale; Dis-P2, score on PANSS P2 item Conceptual Disorganization; Dis-CogSyn, Disorganization score on Cognitive Syndrome factor; Dis-5Fact, Disorganization factor score; AP, Antipsychotic; CPZ eq dose/d, Chlorpromazine equivalent dose per day; Str, Stroop test; Trl, Trailmaking test; CVLT, California Verbal Learning Test; CPT d', Continuous Performance Test d-prime; FingerTp, Fingertapping test; RT, Reaction Time; W-Obj, within-object; B-Obj, between-object; BORT – WORT, between-object RT minus within-object RT;</p

Grand averaged ERPs to cues (red) and non-cued non-targets (black) in the CPTax.

<p>The ERPs are shown of controls (upper 6 panels) and patients (middle 6 panels), at the same electrode positions as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0078062#pone-0078062-g001" target="_blank">Figure 1</a>. The bottom two panels show the differences between the ERPs in the upper and middle panels as cue minus non-target difference potentials at the PO7 and PO8 electrodes for patients (red) and controls (black). The Contingent Negative Variation (CNV) is clearly visible at the Cz electrode as the large negative potential in the late part of the red waveform. </p

Grand averaged ERPs to cued targets (red) and cued non-targets (black) in the CPTax.

<p>The ERPs are shown of controls (upper 6 panels) and patients (middle 6 panels), at the same electrode positions as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0078062#pone-0078062-g001" target="_blank">Figure 1</a>. The bottom two panels show the differences between the ERPs in the upper and middle panels as target minus non-target difference potentials at the PO7 and PO8 electrodes for patients (red) and controls (black). </p

Grand averaged ERPs to targets (red) and non-targets (black) in the CPTx.

<p>The ERPs are shown of controls (upper 6 panels) and patients (middle 6 panels), at central (C3/z/4) and parieto-occipital electrode positions (PO7/8, Pz). Negative amplitudes are plotted upwards. At especially the PO7 electrode at about 200 ms, the red ERP (targets) has more negative amplitude than the black ERP (non-targets). This is the Selection Negativity (SN). The bottom two panels show the differences between the ERPs in the upper and middle panels as target minus non-target difference potentials at the PO7 and PO8 electrodes for patients (red) and controls (black).</p

Prisma 2009 Flow Diagram.

<p>Prisma 2009 Flow Diagram.</p

Effects of lifestyle interventions on cardiometabolic risk.

<p>*Total N in intervention groups.</p>+<p>Total N in control groups.</p>#<p>Attux et al. (2013), Daumit et al. (2013), Evans et al. (2005), Forsberg et al. (2008), Iglesias-Garcia et al. (2010), McKibbin et al. (2006), Methapatara et al. (2011), Poulin et al. (2007), Scheewe et al. (2013) & Wu RR et al. (2008).</p>$<p>Attux et al. (2013), Brar et al. (2005), Brown & Smith et al. (2009), Daumit et al. (2013), Forsberg et al. (2008), McKibbin et al. (2006) & Scheewe et al. (2013).</p>£<p>Forsberg et al. (2008), McKibbin et al. (2006) & Scheewe et al. (2013).</p>δ<p>Attux et al. (2013), Daumit et al. (2013), Forsberg et al. (2008), Mauri et al. (2008), McKibbin et al. (2006), Poulin et al. (2007), Scheewe et al. (2013 &, Wu MK et al. (2007).</p>Δ<p>Attux et al. (2013), Daumit et al. (2013), Forsberg et al. (2008), Mauri et al. (2008), McKibbin et al. (2006), Poulin et al. (2007), Scheewe et al. (2013) & Skrinar et al. (2005).</p>θ<p>Attux et al. (2013), Daumit et al. (2013), Mauri et al. (2008), McKibbin et al. (2006) & Poulin et al. (2007).</p>§<p>Attux et al. (2013), Daumit et al. (2013), Forsberg et al. (2008), Mauri et al. (2008), McKibbin et al. (2006), Poulin et al. (2007) & Wu MK et al. (2007).</p>¶<p>Attux et al. (2013), Daumit et al. (2013), Mauri et al. (2008), McKibbin et al. (2006), Poulin et al. (2007), Scheewe et al. (2013), Wu MK et al. (2007) & Wu RR et al. (2008).</p>ψ<p>Attux et al. (2013), Daumit et al. (2013), Forsberg et al. (2008), Mauri et al. (2008), Wu MK et al. (2007) & Wu RR et al. (2008).</p><p>Effects of lifestyle interventions on cardiometabolic risk.</p

Forest plot a) describes the effects of lifestyle interventions on bodyweight.

<p>Forest plot b) describes the longterm effects of lifestyle interventions on body weight. Forest plot c) describes the effects of lifestyle interventions on depressive symptoms.</p

fMRI results for the contrast Attend negative>Suppress.

<p>L, Left; R, Right; MNI, Montreal Neurological Institute.</p

Experimental design for a single trial.

<p>The task consisted of 110 trials (22 neutral and 88 negative). A single trial lasted 15,5 seconds. Every 9 or 10 trials were followed by a fixation cross of 20 seconds.</p

DMN in schizophrenia patients.

<p>Components map of the DMN of patients controls showing the anterior DMN on the left and the posterior part on the right (p<.001; k >10).</p